Outsourcing in Clinical Trials East Coast 2017 King of Prussia, PA, May
|
|
- Tracy Hamilton
- 5 years ago
- Views:
Transcription
1 Outsourcing in Clinical Trials East Coast 2017 King of Prussia, PA, May Outsourcing in Clinical Trials East Coast brings together the clinical operations and outsourcing community from pharma, biotech and medical device companies from Pennsylvania, New Jersey, New York and beyond to discuss the latest challenges in clinical operations and outsourcing. Speakers include: Mitchell Katz, Head of Clinical Research & Drug Safety Operations, Purdue Pharma Ken Getz, Director, Sponsored Research Programs, Tufts CSDD Faye O Brien, Outsourcing Programme Director, Global Medicines Development, AstraZeneca Bari Kowal, Head of Clinical Trial Management, Regeneron Pharmaceuticals Richard Robinson, Director, Clinical Operations Lead, Pfizer Susan Lubin, Director, Clinical Pharmacology Medical & Operations Group, Bristol-Myers Squibb Frank Leu, Chief Executive Officer, Novapeutics Sameer Tandon, Head of Strategic Alliances, Novartis Ratan Ratnesh, Director, Clinical Outsourcing, Otsuka Stuart Halasz, Associate Director, Clinical Quality Management, Merck Charlotte French, Senior Director, Service Provider Management, EMD Serono Debora Araujo, Associate Director, Clinical Contracting Services, Boehringer Ingelheim Michele Stonier, CRO Infrastructure Lead, Bristol-Myers Squibb Rick O Hara, Associate Director, Project Management and Business Operations, Endo Michael Snyder, Director, Clinical Operations, ContraVir Pharmaceuticals Rosalie Filling, Senior Director, Head of Clinical Operations, Lupin Pharmaceuticals Beth A. Soffer, Senior Director, Quality Preformance & Risk Management, Pfizer Inc. Terrence Tormey, Vice Chairman, Prevention Pharmaceuticals Carrie Lewis, Associate Director, Clinical Operations, Lupin Inc. Craig Coffman, Executive Director, Clinical Business Operations & Outsourcing, Nektar Therapeutics Evan Tzanis, Senior Vice President Clinical Development and Clinical Operations, Paratek Pharmaceuticals Ramzey Odetalla, Sr. Director, Clinical Research, Noven Pharmaceuticals Jennifer Sheller, Executive Director, Clinical Operations, Kyowa Kirin Pharmaceutical Development Sponsors include:
2 Outsourcing in Clinical Trials 2017 Day One May Programme Day One 7:50 Registration and refreshments 8:20 Chairman s opening remarks 8:30 Opening Keynote: Developing lean models for outsourcing of clinical development to meet the demands of recent trends within the industry Exploring experiences, thoughts and lessons learned from companies that have employed lean models to identify the use of such strategies Discussing the decision paradigms that led to the need to use lean sourcing strategies Considering the nature of the models employed to investigate their benefits, challenges and key success factors Investigating key decision that need to considered to ensure successful lean outsourcing Speaker: Mitchell Katz, Head of Clinical Research & Drug Safety Operations, Purdue Pharma 9:00 Session reserved for QuintilesIMS 9:30 Panel Discussion: Exploring how sponsors can use KPIs to measure quality to identify where time and resources need to be allocated to solidify the partnership Defining what is truly meant by KPIs and highlighting the differences between KPIs and metrics to ensure this language is being used correctly Emphasizing the need to simplify the KPI process to measure quality in a quantitative way to allow for comparison of vendors Considering which internal teams should be involved in developing KPIs for vendors to allow quality to be measured effectively Working transparently with vendors to develop effective and realistic KPIs whilst promoting accountability for tasks Considering the option of vendors providing KPIs to sponsors to encourage a true partnership that puts onus on both partners Evaluating how KPIs should change depending on project and vendor category and size Panellists: Faye O Brien, Outsourcing Programme Director, Global Medicines Development, AstraZeneca & Bari Kowal, Head of Clinical Trial Management, Regeneron Pharmaceuticals & Ramzey Odetalla, Sr. Director, Clinical Research, Noven Pharmaceuticals
3 10:00 Session reserved for Sponsor 10:30 Morning Refreshments & Networking Mid-Sized to Big Pharma Stream Small Company Stream 11:00 Developing oversight strategies to ensure effective management of CROs and other vendors and avoid trial delays Exploring the need to tailor your oversight strategies depending on vendor and sponsor size, past experience and location Dealing effectively with missed deliverables to ensure accountability whilst maintaining a solution oriented focus Developing well established specifications alongside pre-agreed milestones to clearly measure partnership success Considering who internally should be managing the outsourcing relationship to ensure the required resources are assigned Evaluating how best to go about portfoliolevel reporting and analytics for more effective oversight Speaker: Susan Lubin, Director, Clinical Pharmacology Medical & Operations Group, Bristol-Myers Squibb Exploring key aspects that need to be addressed as a start-up company moving from the preclinical to clinical space to make this transition as smooth as possible Highlighting differences when selecting and working with pre-clinical and clinical CROs to identify the best outsourcing model Considering how to go about launching international trials to highlight the reliance on CROs for smaller companies Prioritising resources and budgets to ensure costs are allocated in the most productive way Preparing in-depth trial timelines with appropriate required actions to ensure any new vendor services are identified as early as possible Appreciating the need for extra internal resources that may be required to manage additional vendors Speaker: Frank Leu, Chief Executive Officer, Novapeutics 11:30 Session reserved for SynteractHCR Session reserved for Sponsor 12:00 Panel Discussion: Considering strategies to overcome issues with staff turnover both internally and externally Evaluating what can be done to encourage CRA and investigator buy-in into your trial to reduce likelihood of turnover Encouraging the CRO to involve the sponsor in the selection of replacement staff to ensure they are the right fit for the Panel Discussion: Debating what should be considered at the start of a trial to build effective partnerships Identifying what should be included in a typical RFP to facilitate the comparison of bids Emphasizing the need for a concise but thorough Scope of Work to be provided to ensure suitable responses are received
4 trial Investigating the option of using retention bonuses as way of saving costs in the long term Assessing the option of working with consultants to avoid dealing with staff turnover on the same scale Recognizing the need for pharma leadership teams to match what is provided to employees at CROs Panellist: Richard Robinson, Director, Clinical Operations Lead, Pfizer Using the questions posed by vendors in responses as an indicator of vendor knowhow and experience Exploring key preparation aspects to consider before the Bid Defense Meeting to ensure the right partner is found for your trial Considering who should be present at the meetings to ensure a streamlined approach whilst obtaining the required input Rick O Hara, Associate Director, Project Management and Business Operations, Endo Michael Snyder, Director, Clinical Operations, ContraVir Pharmaceuticals Rosalie Filling, Sr. Director, Head of Clinical Operations, Lupin Pharmaceuticals 12:30 Session Reserved for Acurian Session Reserved for PSI 1:00 Networking Lunch 2:00 Investigating the state of feasibility assessments and strategies to improve your methodology Considering why, despite technological improvement and real-time access to date, the industry continues to be plagued by common errors and oversights Defining two distinct steps to feasibility; Medical and Operational feasibility to identify the differences between both Investing time and resources into improving feasibility assessments to meet the demands of more complex protocols Exploring different tools that can support the feasibility processes and streamline this process Speaker: Sameer Tandon, Head of Strategic Alliances, Novartis 2:30 Session reserved for INC Research Case Study: Exploring how working with large scale CROs can be the key to international trial management Ensuring you plan in due time for international trial growth in order to guide your vendor selection process Recognizing the need for an increased spend on a global CRO at the outset to avoid incurring extra costs as your trial expands Considering how best to capitalize on a vendors global reach to ensure you are getting what you paid for Overcoming any issues with being seen as a second class customer by large scale CROs Michael Snyder, Director, Clinical Operations, ContraVir Pharmaceuticals Optimizing sponsor/cro relationships to ensure the success of your clinical trials
5 Understanding key factors that drive Sponsor-CRO relationships Providing tips for negotiation Discussing financial management and reporting Reviewing several short case studies Kristen Snipes, Project Director, Rho 3:00 Establishing an end-to-end approach to business operations for clinical research to allow for more effective forecasting and budgeting Promoting the idea of business operations and outsourcing teams being under the same management to avoid any knowledge being lost Considering how best to build links between project management and business operations to improve forecasting and budgeting processes Ensuring specific plans and processes for each team when change order occurs to minimize their impact Developing plans for forecasting strategies as the trial grows to international levels or takes different avenues Speaker: Charlotte French, Senior Director, Service Provider Management, EMD Serono Building effective management strategies when working with third party vendors to secure oversight across all aspects of the trial Setting out clear expectations of any third party vendors with a full service CRO at the outset Defining metrics to clarify when sponsors should interfere to ensure quality standards to not slip Ensuring roles are accurately and transparently defined to avoid duplication of efforts and costs from multiple parties Considering the benefits of allowing CROs to centrally manage other vendors to promote the idea of a true partnership Debating whether CROs will negotiate effectively to ascertain whether they can maintain required level of costs Carrie Lewis, Associate Director, Clinical Operations, Lupin Pharmaceuticals 3:30 Afternoon Refreshments & Networking 4:00 Recognizing what can be done by all partners, staff and stakeholders to improve inspection readiness Promoting the idea of being in a constant state of preparation rather than preparing for a one-off inspection Emphasizing the need for effective TMF management; ensuring data is not only collected in the right way but also accessible when required Debating what senior management within both sponsors and CROs need to do to ensure a culture of compliance Questioning whether electronic TMF can be a solution or an obstacle in future trial management Ensuring all required staff, internally and externally, locally and globally are aware of requirements
6 and are reachable to improve response times Exploring other technological solutions to improving trial management and improving success rates during inspection Speaker: Stuart Halasz, Associate Director, Clinical Quality Management, Merck 4:30 Taking a risk-based approach using advanced analytics to oversee vendors and investigative sites- A Case Study Ensuring the health of investigative sites requires a more evolved approach in the way we deploy recourses, manage risks and quality issues, and identify trends Building the story with analytical tools ensures effective oversight of quality and performance to prevents poor outcomes Incorporating the direction of ICH E6 Revision 2 which is helping to drive the approach to ensuring quality in clinical trials Beth A. Soffer, Senior Director, Quality Performance & Risk Management, Pfizer Inc 5:00 Chairman s closing remarks and close of Day One Outsourcing in Clinical Trials 2017 Day Two 24 th May 2017 Programme Day Two 8:15 Registration and refreshments 8:50 Chairman s opening remarks 9:00 Stream A: Pharma and Biotech Considering how best to engage with all stakeholders to develop trial strategies that fit the needs to all parties and is most beneficial to patients Recognizing what different stakeholders can stand to gain from your trial to allow for a more targeted approach to engagement Evaluating how best to work with patient groups to develop patient-centric trials to improve patient retention and recruitment rates Stream B: Medical Device Evaluating best practice for identifying and qualifying suppliers discovering engaging sites that adjust and deliver beyond expectations Identifying successful sites within specific fields who accommodate to your needs working towards a common goal Assessing methods to ascertain expert medical staff to work with encouraging a smooth running of the trial Investigating multiple suppliers to identify who carries out the most suitable enrolment process for your study
7 Considering how to find sites that are looking to engage, and developing processes that simplify tasks for trial to ensure effective collaboration Highlighting the benefits of working with CROs that have their own site networks whilst being sure to not be influenced by this when developing site relationships Developing communication routes between senior level sponsor executives and sites to ensure they are aware of the specific trial and sponsor needs Qualifying site coordinators and encouraging frequent communication promoting effective project management Gabriela Gottlieb, MPH, Regulatory and Clinical Affairs Manager, Maxx Orthopedics Craig Coffman, Executive Director, Clinical Business Operations & Outsourcing, Nektar Therapeutics 9:30 Embracing Opportunity in the Asia-Pacific: Identifying and building opportunities in the world s most dynamic region. Identifying and debunking the common misconceptions that exist around conducting clinical trials in the Asia-Pacific region Examining various recruitment and retention strategies and trends in the Asia- Pacific Outlining opportunities to save time and money in specific countries and throughout the broader region Identifying and discussing opportunities (Predominance of western diseases, facilities, literacy rates, technology usage and prescribing patterns, for example) and how these will impact on clinical trials and future practice studies in the region. Dr Maria Ali, Associate Director, Medical & Regulatory Services, George Clinical Striking the balance between outsourcing and using in-house resources to improve efficiency in your trial Evaluating your internal expertise to decide which processes to outsource ensuring you make the most of in-house capabilities and continue being costeffective Addressing advantages and challenges of hybrid vs full outsourcing models identifying which is more suitable for your company Ensuring you are attracting successful suppliers who will provide clinical and regulatory experts to work with you on your device trial Uncovering a small companies perspective on which model of outsourcing is the most cost-effective method to remain within the budget restrictions Cathy Dawson, Director Clinical Affairs, Aesculap 10:00 Case Study: Developing strategies for when it all goes wrong; considering how to maintain relationships when challenges occur Recognizing what the sponsor can do as Exploring the development of combination products and recent guidelines that will influence the developmental process Identifying recent guidelines and clinical
8 soon as red flags are raised to reduce the impact of any issues Creating effective escalation strategies within the contract in case of any issues to facilitate quick solutions Re-establishing communication with vendor business development teams in case of under delivery Does the end mean the end; ensuring bridges aren t burnt in the event you need to change CROs mid-trial Learning from past lessons to highlight what must be thought about from the outset to avoid issues midway through the trial factors to consider when undergoing a trial involving combination products Addressing the different regulatory pathways available for combination products and how this impacts all aspects of product development Overcoming challenges associated with review management to ensure your product gets to market as efficiently as possible Lori-Anne Woodard, Senior Manager Quality Compliance Combination Products, Teva Pharma Evan Tzanis, Senior Vice President Clinical Development and Clinical Operations, Paratek Pharmaceuticals 10:30 Morning Refreshments & Networking 11:00 Implementing investigator site payment strategies for success in outsourced trials 11:30 Identifying opportunities before and during Clinical Trial Agreement negotiations for site payment success regardless of outsourcing model Automation, transparency and centralization for improved overall site payment experience Engaging sites early to avoid potential bottlenecks during the site payment stage Customizing the site payment approval process for improved payment cycle times Exploring the implementation of site feedback mechanisms as a way of constantly improving site payment relationships Debora Araujo, Associate Director, Clinical Contracting Services, Boehringer Ingelheim Exploring the importance of inclusion of diverse patient populations in clinical trials Comparing the advantages and regulatory requirements involved with undertaking a Registry vs IDE (Investigational Device Exemption) study Identifying the FDA-associated hurdles involved for each option ensuring the credibility of your study Addressing the pivotal nature of each study in order to optimise time-efficiency and cost-effectiveness Examining source verification documents requirements to assure GCP compliance Comparing the level of work required for IDE vs a non-ide study to decide which option is most suitable for you Uncovering the value of implementing a Registry study for medical devices and how to run it economically to successfully move through the post-market phase Steve Sisk, Director, Clinical Operations, CytoSorbents Corporation Addressing the trials and tribulations of
9 12:00 Investigating the importance of racial and ethnic balancing in clinical development Exploring reasons for under-representation of minorities Developing strategies to increase representation of minorities Analysing FDA involvement in the inclusion of diverse patient populations in clinical trials Dr. Alfonso Alanís, Chief Medical and Development Officer, Research Point Small Pharma: Building efficient, effective quality oversight & governance model Transitioning from "big" to small pharma Trial management role harmonization with risk based oversight Executive Management Oversight - Governance Model Identifying and engaging with ideal vendors / CROs for your organization -- streamlining, preferred vendor model Jennifer Sheller, Executive Director, Clinical Operations, Kyowa Kirin Pharmaceutical Development outsourcing medical device studies in smaller companies to adhere to strict timelines and budgets Hear from 2 innovative 15 minute presentations on the hurdles faced by smaller device companies and discuss possible solutions to them, followed by 25 minutes Q&A. Identifying challenges faced when working with vendors who lack experience working with start-ups to establish expectations and guidelines Highlighting the importance of economic and timeline constraints compared to larger companies to guarantee the site understands the study objectives Addressing enrolment challenges faced by smaller companies to ensure you recruit the right patient population which in turn reflects the validity of the study Emphasizing the importance of CROs being flexible with their protocol to fit with the companies restrictions and work together effectively Presentation 1: Baruch Ben-Dor, Chief Executive Officer, InfraScan Presentation 2: Helen Hahn, Director Medical Affairs, Alliqua Panellists: Baruch Ben-Dor, Chief Executive Officer, InfraScan; Cathy Dawson, Director Clinical Affairs, Aesculap; Helen Hahn, Director Medical Affairs, Alliqua; Heidi Goldsmith, Director of Clinical Studies, Aspire Bariatrics 12:30 Networking Lunch 1.45 A Rational Approach to Managing Sponsor Vendor Relationships Outsourcing relationships are often driven by irrational management approaches such as personality compatibility or non-scientific metrics. In this presentation, I will describe a scientific Defining strategies such as remote monitoring to ensure the correct level of oversight required occurs throughout the study Identifying the importance of partnerships between vendors and medical device
10 approach to managing outsourcing relationships. At the end of this session, attendees will be able to: describe the shortcomings in current approaches to clinical trial performance measurement, follow the scientific methods for creating their own performance measures that are valid and reliable in their specific context, - use these scientific measures to rationally guide sponsor vendor relationships Michael Howley, Associate Clinical Professor, Drexel University companies to ensure all stakeholders are working towards a common goal Promoting face-to-face meetings with the vendor before the trial begins to delegate responsibilities and identify risks in advance Defining regular points of contact between CRO and site during the trial to keep to the timeline and confirming the project plan aligns with stakeholders Examining the idea of remote monitoring to ensure the trial and budgets are managed accordingly Dana Keane, Clinical Affairs Director, Optos 2.15 The Changing Outsourcing Landscape and its Impact on Drug Development Operating Conditions Reviewing new data characterizing the structure of the market for outsourced services Highlighting major trends and M&A activity driving consolidation and operating change Discussing strategies anticipating landscape change to drive development performance Speaker: Ken Getz, Director, Sponsored Research Programs, Tufts CSDD Addressing the use and collection of CGM (Continued Glucose Monitoring) data in a clinical trial and also other med devices Addressing all stages from protocol design to data analytics to apply the device to a trial and maintain it throughout End point consideration- addressing what to do with data and understanding what you want to get out of the trial to ensure success Establishing the steps involved with trial initiation and maintenance Identifying methods of data analysis and normalisation to easily assess the data collected from the CGM device Robert Sala, Director, Dexcom 3:00 Afternoon Refreshments & Networking 3:30 Speaker Hosted s Each roundtable session lasts for 40 minutes, and delegates may attend up to 2 roundtables Biopharma 1 Developing best practices for outsourcing in rare disease trials
11 Medical Device 1 Biopharma 2 Medical Device 2 Biopharma 3 Biopharma 4 Developing a comprehensive approach to CRO selection to reduce time to study start-up Facilitator: Duane R Dey, Director Clinical Affairs, Ortho Clinical Diagnostics reserved for George Clinical Discussing how to get a balance between outsourcing and utilizing in-house resources to maximize efficiency in your device trial Helen Hahn, Director Medical Affairs, Alliqua Investigating the true value of Risk Based Monitoring Developing effective infrastructures for effective management of CROs Facilitator: Michele Stonier, CRO Infrastructure Lead, Bristol-Myers Squibb 4:50 Chair s summation and close of conference
Outsourcing in Clinical Trials East Coast 2017 King of Prussia, PA, May
Outsourcing in Clinical Trials East Coast 2017 King of Prussia, PA, May 23-24 2017 Outsourcing in Clinical Trials East Coast brings together the clinical operations and outsourcing community from pharma,
More informationOutsourcing in Clinical Trials 2017 Day One May Programme Day One
Outsourcing in Clinical Trials 2017 Day One May 23 2017 Programme Day One 7:50 Registration and refreshments 8:20 Chairman s opening remarks 8:30 Opening Keynote: Developing lean models for outsourcing
More informationOutsourcing in Clinical Trials West Coast: Medical Device Stream Burlingame, CA February 22 nd 2018
Outsourcing in Clinical Trials West Coast: Medical Device Stream Burlingame, CA February 22 nd 2018 Speakers Confirmed: Lian Cunningham, Vice President, Clinical Affairs and Regulatory Affairs, BAROnova
More information2018 Confirmed Speakers
The leading clinical trial supply series delivering localised content to key biopharma clusters 2018 Confirmed Speakers Eyal Ron, Chief Technology Officer, Gelesis Michael Sparozic, Trial Supplies Operation
More information10:00 Examining the Challenges with Sourcing the Right CRO and Vendors for Global Trials
Outsourcing in Clinical Trials East Asia 6 th December 2017 Program Day One 08:30 Registration and Refreshments 08:50 Chair s Opening Speech 09:00 The Key Elements to Success: Learning about the Essential
More informationMeeting sponsor s criteria : strategy to collaborate, engage and deliver
Meeting sponsor s criteria : strategy to collaborate, engage and deliver Frédérique Couttet Clinical Trial Manager 4th Annual Outsourcing in Clinical Trials Europe Brussels, Switzerland, May 21 22, 2014
More informationCLINICAL TRIAL SUPPLY EAST COAST 2017
CLINICAL TRIAL SUPPLY EAST COAST 2017 18 TH -19 TH OCTOBER 2017 PRINCETON, NEW JERSEY SPEAKING FACULTY Reid Tonik, Director, Global Clinical Supply Chain, Teva Pharmaceuticals Anthony Orosz, Assistant
More informationDRAFT DOCUMENT FINAL COPY TO REFLECT CONFIRMED. Embed Innovations to Transform Your R&D Procurement Model and. Drive Scientific Activities Efficiency
Embed Innovations to Transform Your R&D Procurement Model and Drive Scientific Activities Efficiency April 30 May 1, 2018 Boston, US This conference exceeded all of my expectations. The topics, speakers
More information2019 Speakers Confirmed:
2019 Speakers Confirmed: Sharon Goldfarb, VP Regulatory & Clinical, GI View Avraham Biran, Director Clinical, Regulatory & Quality, BlueWind Medical Tsvia Erlich, VP Regulatory & Clinical Affairs, ConTIPI
More informationTestimonials from OCT Attendees: 2018 Speakers Include:
Exploring innovative strategies in clinical outsourcing and operations to optimise trial outcomes Testimonials from OCT Attendees: At OCT, I greatly value the opportunity to reconnect with old friends/colleagues
More information08:20 Chair s opening remarks Agenda Highlight!
Program Day One 7 th September 2016 07:30 Registration and refreshments 08:20 Chair s opening remarks Agenda Highlight! 08:30 KEYNOTE PRESENTATION Identifying the real meaning of a strategic partnership
More informationFinding the Balance between Clinical & Commercial Key Roles. Stewart Geary Chief Medical Officer, Senior Vice President, Eisai, Japan
IBC LIFE SCIENCES Part of: 4 TH ANNUAL Grand Copthorne Waterfront Hotel, Finding the Balance between Clinical & Commercial Key Roles Expert Faculty Include: Ajay Tiku Vice President Medical, Asia Pacific,
More information2019 Speakers Confirmed:
2019 Speakers Confirmed: Sharon Goldfarb, VP Regulatory & Clinical, GI View Avraham Biran, Director Clinical, Regulatory & Quality, BlueWind Medical Tsvia Erlich, VP Regulatory & Clinical Affairs, ConTIPI
More informationCLINICAL TRIAL SUPPLY EAST COAST 2017
CLINICAL TRIAL SUPPLY EAST COAST 2017 18 TH -19 TH OCTOBER 2017 PRINCETON, NEW JERSEY SPEAKING FACULTY Reid Tonik, Director, Global Clinical Supply Chain, Teva Pharmaceuticals Anthony Orosz, Assistant
More informationCLINICAL TRIAL SUPPLY EAST COAST 2017
CLINICAL TRIAL SUPPLY EAST COAST 2017 18 TH -19 TH OCTOBER 2017 PRINCETON, NEW JERSEY SPEAKING FACULTY Reid Tonik, Director, Global Clinical Supply Chain, Teva Pharmaceuticals Anthony Orosz, Assistant
More informationCLINICAL TRIALS SUPPLY NEW ENGLAND
CLINICAL TRIALS SUPPLY NEW ENGLAND 26 TH -27 TH MARCH BOSTON, MASSACHUSSETS Developing best practices and incorporating novel technologies to meet the demands of a more complex, international clinical
More informationHow to rescue a clinical trial
How to rescue a clinical trial Clinical trial conduct is demanding and rigorous, especially in orphan indications where patient populations are small. Even well-qualified, specifically selected Contract
More information08:20 Chair s opening remarks Agenda Highlight!
Program Day One 7 th September 2016 07:30 Registration and refreshments 08:20 Chair s opening remarks Agenda Highlight! 08:30 KEYNOTE PRESENTATION Identifying the real meaning of a strategic partnership
More informationBEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM
BEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM Six steps to ensuring risk-based quality management in clinical trials EVOLVING REGULATIONS ON RISK-BASED MONITORING In 2016, the International
More informationOutsourcing in Clinical Trials Southern California 2017 September 27 th 28 th La Jolla, California
Outsourcing in Clinical Trials Southern California 2017 September 27 th 28 th La Jolla, California 2017 Speaking Faculty Larn Hwang, CSO, Autotelic Inc Mathias Schmidt, CEO, ArmaGen Dr. Vlad Bogin, CEO,
More informationAnalyzing which software needs to be utilized to ensure a timely and more automated process
Clinical Data Integration & Management March 20 th Program Day One 08:15 Registration and refreshments 08:50 Chair s opening remarks Analyzing which software needs to be utilized to ensure a timely and
More informationOUTSOURCING IN CLINICAL TRIALS SOUTH EAST
OUTSOURCING IN CLINICAL TRIALS SOUTH EAST March 13 th -14 th, 2018 I Durham, North Carolina, USA 2018 Speaking Faculty Nicole Leedom, Director Clinical Operations, SpringWorks Therapeutics William Gluck,
More informationClinical Performance Metrics & Benchmarking Summit
EXECUTIVE SUMMARY 10th Clinical Performance Metrics & Benchmarking Summit CONTENTS INTRODUCTION 3 PRESENTATIONS 4 FOR MORE INFORMATION 7 INTRODUCTION If you weren t able to join us this year, here is what
More informationEvaluation of the Prime Partnership between Accelence and Quintiles. James Brook Senior Director, Head Site Management Western Europe, Quintiles
Evaluation of the Prime Partnership between Accelence and Quintiles James Brook Senior Director, Head Site Management Western Europe, Quintiles Copyright 2013 Quintiles Revised July 2013 7 BILLION HUMANS
More informationSponsor/CRO Partnership Optimization
Insight Brief Sponsor/CRO Partnership Optimization Developing a CRO Governance Model Geoff Garabedian, Vice President and Managing Director, Consulting at Quintiles Josh Samon, Principal Life Sciences
More information10 th Annual Pharma Packaging and Labeling East Coast Conference
10 th Annual Pharma Packaging and Labeling East Coast Conference February 21 st 22 nd, 2018 Philadelphia, USA 2018 Speaking Faculty Patricia Walsh, Director, Head of Global Labeling, Jazz Pharmaceuticals
More informationENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL
Shaping the Future of Drug Development ENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL Jim Baker Senior Vice President Clinical Research Services Cytel JIM BAKER Senior
More informationPRE-CONFERENCE MEDICAL WRITING AND COMMUNICATIONS BOOT CAMP
PRE-CONFERENCE MEDICAL WRITING AND COMMUNICATIONS BOOT CAMP Wednesday, October 24th, 2018 Come prepared for dynamic workshops as you learn with some of the brightest minds in the field! 8:00 AM 9:00 AM
More informationCLINICAL TRIALS SUPPLY NEW ENGLAND
CLINICAL TRIALS SUPPLY NEW ENGLAND 26 TH -27 TH MARCH BOSTON, MASSACHUSSETS Developing best practices and incorporating novel technologies to meet the demands of a more complex, international clinical
More information3rd Annual Global Drug Bioavailability Enhancement Summit
3rd Annual Global Drug Bioavailability Enhancement Summit Event Summary Most drugs on today s market display poor solubility, but the use of modern solubilization technologies can improve a drug product
More informationRBM Risk Based Monitoring GCP Training 12/SEP/2015. Gabor Kiss Synexus Hungary2015
RBM Risk Based Monitoring GCP Training 12/SEP/2015 Gabor Kiss Synexus Hungary2015 Agenda Why traditional monitoring must change? The landscape Regulatory Industry IT What can we expect? Transition period
More informationAn Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies. SPEAKER: Suzanne Murray Biogen
An Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies SPEAKER: Suzanne Murray Biogen Contents 1. BioPhorum Operations Group (BPOG) and the Post-approvals
More informationTransCelerate A collaboration to find solutions to critical industry challenges
TransCelerate A collaboration to find solutions to critical industry challenges Katrina Campion Regional Director Asia Pacific - Clinical Operations GlaxoSmithKline 1 Faculty Disclosure In compliance with
More informationCreating the ideal Approach to gain Balance between effective Oversight and Micromanaging
Creating the ideal Approach to gain Balance between effective Oversight and Micromanaging Karine Pigache-Renard and on behalf of Ulrike M. Grimm 4 th Annual Outsourcing in Clinical Trials Europe Conference,
More informationOutsourcing in Clinical Trials Nordics October 30 th 31 st Copenhagen
Outsourcing in Clinical Trials Nordics 2018 October 30 th 31 st Copenhagen 2018 Speakers Confirmed: Magnus Björsne, CEO, AstraZeneca BioVentureHub Mikkel Skovborg, Executive Specialist, NovoNordisk Thomas
More informationRecommendations for Strengthening the Investigator Site Community
Recommendations for Strengthening the Investigator Site Community October 2017 CTTI MISSION: To develop and drive adoption of practices that will increase the quality and efficiency of clinical trials
More informationAbout Preclinical Development Operations Summit
Prioritizing the sourcing and management of preclinical vendors for faster and more successful candidate development About Preclinical Development Operations Summit The Preclinical Development Operations
More informationVendor-Sponsor Successful Communication. Nathalie Dutil Nov 2012
Vendor-Sponsor Successful Communication Nathalie Dutil Nov 2012 It s all about setting expectations. Lack of communication Miscommunication Presentation overview Strategic Sourcing Oversight Model Trust
More informationFRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up?
FRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up? The following framework of characteristics focuses on attributes that are within the control of investigators and their
More informationCLINICAL TRIAL SUPPLY EAST COAST 2017
CLINICAL TRIAL SUPPLY EAST COAST 2017 18 TH -19 TH OCTOBER 2017 PRINCETON, NEW JERSEY SPEAKING FACULTY Anthony Orosz, Assistant Director, Pharmaceutical, Health and Chemical Center of Excellence and Expertise,
More information08:20 Chair s opening remarks Agenda Highlight!
Program Day One September 7 th, 2016 07:30 Registration and refreshments 08:20 Chair s opening remarks Agenda Highlight! 08:30 KEYNOTE PRESENTATION Identifying the real meaning of a strategic partnership
More informationBuilding a foundation to advance clinical trial processes through UK focused innovation admits dynamic regulatory and political environment
Building a foundation to advance clinical trial processes through UK focused innovation admits dynamic regulatory and political environment The 5 th Annual Outsourcing in Clinical Trials UK & Ireland 2018
More informationDEVELOPING PRACTICAL STRATEGIES FOR IMPROVING YOUR CLINICAL TRIAL PARTNERSHIPS TO EXPEDITE DRUG DEVELOPMENT Event Outlook Speaking Faculty
DEVELOPING PRACTICAL STRATEGIES FOR IMPROVING YOUR CLINICAL TRIAL PARTNERSHIPS TO EXPEDITE DRUG DEVELOPMENT Event Outlook BRAND NEW TOPICS FOR A DACH AUDIENCE THE LEADING OUTSOURCING SERIES IN EUROPE NETWORKING
More informationProject Delivery Excellence
Project Delivery Excellence Raising the bar in project success 1 ICONplc.com Contents Raising the bar in project success 03 Tailored training and development 04 Project planning and management for predictable
More informationCLINICAL TRIAL SUPPLY EAST COAST 2017
CLINICAL TRIAL SUPPLY EAST COAST 2017 18 TH -19 TH OCTOBER 2017 PRINCETON, NEW JERSEY SPEAKING FACULTY Anthony Orosz, Assistant Director, Pharmaceutical, Health and Chemical Center of Excellence and Expertise,
More informationCLINICAL TRIAL SUPPLY EAST COAST 2017
CLINICAL TRIAL SUPPLY EAST COAST 2017 18 TH -19 TH OCTOBER 2017 PRINCETON, NEW JERSEY SPEAKING FACULTY Reid Tonik, Director, Global Clinical Supply Chain, Teva Pharmaceuticals Anthony Orosz, Assistant
More informationMulti-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes
WHITE PAPER Multi-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes Author: SCOTT SCHLIEBNER Vice President, Rare Disease - Scientific Affairs
More informationArena International s Inaugural Outsourcing in Clinical Trials Southern California, La Jolla.
Arena International s Inaugural Outsourcing in Clinical Trials Southern California, La Jolla. Program Day One September 24 th 2013 07:45 08:20 Registration and refreshments Chair s opening remarks Sarah
More informationWorking together to achieve shared goals in product packaging and labeling
Working together to achieve shared goals in product packaging and labeling Following on from our 10th anniversary edition Pharma Packaging and Labeling will be returning to Philadelphia for its 11th edition.
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More informationSingapore Clinical Research Professional (CRP) /Clinical Research Coordinator Society (CRCS) Forum
Singapore Clinical Research Professional (CRP) /Clinical Research Coordinator Society (CRCS) Forum 25 August 2017 TOPIC: Issue Management / Quality Risk Management Implications with ICH GCP E6 (R2) and
More informationSelecting A Right Patient Recruitment Company: The Key To Success
Selecting A Right Patient Recruitment Company: The Key To Success A R T I C L E Toll Free Number: 1-888-987-2691 www.makrocare.com/mcsmo 1 With current global economic uncertainty, intense global competition,
More informationWorking together to achieve shared goals in product packaging and labeling
Working together to achieve shared goals in product packaging and labeling Following on from our 10th anniversary edition Pharma Packaging and Labeling will be returning to Philadelphia for its 11th edition.
More informationQUALITY ASSURANCE. Pharma Quality Agreements: What Are They, and Why They Matter For Your Study ABSTRACT
WHITE PAPER PRESENTED BY PREMIER RESEARCH Pharma Quality Agreements: What Are They, and Why They Matter For Your Study ABSTRACT Quality Agreements are an effective bridge to a successful future for companies
More informationCRO Outlook 2015: A Paperless Path to a Competitive Advantage
CRO Outlook 2015: A Paperless Path to a Competitive Advantage Dec 22, 2014 By Jennifer Goldsmith Applied Clinical Trials All signs indicate that 2015 should be another good year for contract research organizations
More informationOutsourcing in Clinical Trials Nordics October 30 th 31 st Copenhagen
Outsourcing in Clinical Trials Nordics 2018 October 30 th 31 st Copenhagen 2018 Speakers Confirmed: Magnus Björsne, CEO, AstraZeneca BioVentureHub Mikkel Skovborg, Executive Specialist, NovoNordisk Thomas
More informationGetting Connected: The Benefits of a Unified Clinical Platform
WHITE PAPER Getting Connected: The Benefits of a Unified Clinical Platform December 2017 Table of Contents 01 Getting Connected: The Benefits of a Unified Clinical Platform 05 New Technologies 04 Changing
More informationwhitepaper managing fluctuating demand through a scalable FSP model. randstad life sciences
whitepaper managing fluctuating demand through a scalable FSP model. randstad life sciences Pharmaceutical companies and the Contract Research Organizations (CROs) that serve them are no strangers to the
More information10th Clinical Performance Metrics & Benchmarking Summit
10th Clinical Performance Metrics & Benchmarking Summit Utilizing Foundational Metrics in a Heavily Data Driven Environment to Ensure High Quality and Efficient Clinical Trials December 4 5, 2013 The Inn
More informationOracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite
Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite April 12, 2012 Oracle is currently reviewing
More informationOutsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla
Outsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla This year s conference has a solid range of emergent topics, a variety of subject matter expert speakers and excellent
More informationImplementing a Metadata Repository Solution - A User Story
Paper DS08 Implementing a Metadata Repository Solution - A User Story Wade Fairbanks, Pfizer, Groton, CT, USA Barrie Nelson, Nurocor, Austin, TX, USA ABSTRACT With a Metadata Repository (MDR) solution
More informationNEXT Annual Report 2017
NEXT Annual Report 2017 June 2018 Final version NEXT Annual Report 2017 Executive Summary The number of early clinical trials carried out in the centers exceeded the number anticipated in the original
More informationInnovative strategies to improve R&D ROI
Innovative strategies to improve R&D ROI Ed Stelmakh, CPA, CMA Vice President and CFO Otsuka America Pharmaceutical, Inc. DISCLAIMER: The following presentation represents the opinions of the speaker and
More informationConfirmed speakers. Sponsors
Confirmed speakers Karen Paese, Director, Clinical Supply Chain Management, Gilead Sciences Richard Horn, Director, Clinical Supplies, Nektar Therapeutics Robert Bottome, Executive Director, Global Supply
More informationERIC LAKE AND CHRIS SEIFARTH
ERIC LAKE AND CHRIS SEIFARTH Contents Introduction... 1 Determine What Relationship to Use... 2 Develop a Working Strategy... 3 Foster Team Environment and Collaboration... 5 What to Expect from Your CRO
More informationLSE Health Market Access Academy April 2018, London September 2018, London
LSE Health Market Access Academy 9 13 April 2018, London 10 14 September 2018, London In cooperation with the Boston Consulting Group Market Access Roundtable LSE Health Market Access Academy 2 The London
More informationClinical Performance Metrics and Benchmarking Summit
EXL PHARMA PRESENTS THE ONLY CLINICAL METRICS EVENT FOR THE INDUSTRY 11th Clinical Performance Metrics and Benchmarking Summit Implement Effective Performance Metrics to Monitor Risk, Site Selection, and
More information2017 Clinical Trials Data Library
2017 Clinical Trials Data Library Copyright 2017 CenterWatch. Investigator Databank Total Active Principal Investigators Worldwide Active Investigators Worldwide Global Distribution of Investigative Sites
More informationDay 2 Stream. Addressing key operational and outsourcing issues for Israeli biopharma and medical device companies engaged in clinical trials
Day 2 Stream Addressing key operational and outsourcing issues for Israeli biopharma and medical device companies engaged in clinical trials 2016 SPEAKERS INCLUDE; Event Chair Day 1; Dr. Sharon Hashmueli,
More information2015 PHARMACEUTICAL MARKET ACCESS IN CHINA SUMMIT
2015 PHARMACEUTICAL MARKET ACCESS IN CHINA SUMMIT September 24 th, 2015 Beijing, China Hear Critical Regulatory Update from Previous & Priority Inviting Keynote Speakers China Food & Drug Administration
More informationTop Challenges with Late Stage Trial Master Files
Top Challenges with Late Stage Trial Master Files The transition from a paper to an electronic Trial Master File (TMF) system is a significant task. In many cases, some pharma and biotech firms (sponsors)
More informationRe-Designing Regulatory Capabilities
Re-Designing Regulatory Capabilities By Randolph Fillmore Faced with growing regulatory burdens, Bristol Myers Squibb (BMS) and Halozyme each committed time and resources to connect regulatory functions
More informationOutsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla
Outsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla This year s conference has a solid range of emergent topics, a variety of subject matter expert speakers and excellent
More informationClinical Trial Performance Metrics
Clinical Trial Performance Metrics Clinical trial performance metrics? Data points that provide insight into operational and quality of performance. Objectives of Clinical Trial Performance Metrics The
More informationJob description and person specification
Job description and person specification Position Job title Head of Genomics Unit Directorate Finance, Commercial and Specialised Commissioning Pay band AFC Band 9 Responsible to Director of Strategy and
More informationmedicines, improving the health of people around the world.
TransCelerate BioPharma Inc. is a non-profit organization with a mission to collaborate across the biopharmaceutical research and development community to identify, design and facilitate the implementation
More informationAna Garcia Canon, ICRO (Clinical Operations) Group Head, Novartis Pharma
Arena International s 7th Annual Outsourcing in Clinical Trials Europe Conference, Barcelona, Spain Program Day One May 16 th 2017 7:40 Registration and refreshments 8:10 Chair s opening remarks 8:15 KEYNOTE
More informationTransCelerate Overview. Tozheg Roshankar
TransCelerate Overview Tozheg Roshankar 11, Aug, 2016 TransCelerate is a not for profit entity created to drive collaboration Our vision To improve the health of people around the world by accelerating
More informationPROGRAM AGENDA- AS OF JULY 28, 2008
PROGRAM AGENDA- AS OF JULY 28, 2008 PLEASE NOTE THAT THIS CONFERENCE AGENDA IS SUBJECT TO CHANGE AS WE CONTINUALLY WORK TOWARDS BRINGING YOU THE BEST POSSIBLE TOPICS AND SPEAKERS. SUNDAY NOVEMBER 9, 2008
More informationAnalyzing which software needs to be utilized to ensure a timely and more automated process
Clinical Data Integration & Management March 20 th Program Day One 07:30 Registration and refreshments 08:15 Chair s opening remarks Terry Katz, Director, Head of DM and Statistics, Merck Animal Health
More informationReady to help lead a dynamic team that is reshaping health care shared services and how they re delivered?
Ready to help lead a dynamic team that is reshaping health care shared services and how they re delivered? Mohawk Medbuy is a national not for profit shared service organization trusted by Canadian hospitals
More informationOutsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla
Outsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla This year s conference has a solid range of emergent topics, a variety of subject matter expert speakers and excellent
More informationinventivhealthclinical.com The Goal: Reducing Uncertainty A Word on RBM
Seeing Around Corners: Risk Assessment Is the Foundation of Risk-Based Monitoring By: Jeff Fetterman, President ParagonRX, an inventiv Health Company, Michael Macri, Director, Strategic Services, inventiv
More informationAn Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America
An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America SPEAKERS: Janett Mugaburu-Richards, M.S. Pfizer Inc. Kavita Ramalingam Iyer, Ph.D Merck & Co., Inc. Contents
More informationKNOW-HOW AND ACCURACY IN CLINICAL RESEARCH
KNOW-HOW AND ACCURACY IN CLINICAL RESEARCH Behind every successful and growing organization lies a strong foundation and a great vision. - Vatché Bartekian President A WINNING TEAM Vatché Bartekian President
More information1201 Maryland Avenue SW, Suite 900, Washington, DC ,
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org May 31, 2012 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville, MD
More informationKNOW-HOW AND ACCURACY IN CLINICAL RESEARCH
KNOW-HOW AND ACCURACY IN CLINICAL RESEARCH Behind every successful and growing organization lies a strong foundation and a great vision. - Vatché Bartekian President A WINNING TEAM Vatché Bartekian President
More informationCRO/SPONSOR COOPERATION: COLLABORATING FOR A SUCCESSFUL OUTCOME
CRO/SPONSOR COOPERATION: COLLABORATING FOR A SUCCESSFUL OUTCOME Vibeke Breinholt Director, Clinical Operations, Ferring Pharmaceuticals A/S 18 September 2014 Presentation Overview 1. How to choose the
More informationDeveloping and Implementing a Comprehensive Clinical QA Audit Program
Developing and Implementing a Comprehensive Clinical QA Audit Program Henry Li 1, *, Susan Hawlk 2, Kim Hanna 1, Gerald Klein 1 and Steve Petteway Jr. 1 1 Talecris Biotherapeutics, 79 T. W. Alexander Drive,
More informationSeven Key Success Factors for Identity Governance
WHITE PAPER Seven Key Success s for Identity Governance Insights and Advice from Real-World Implementations You have been given a high-profile mission: address urgent audit and compliance requirements
More informationEnsuring Quality & Regulatory Compliance when Collaborating with a Service Provider
DPT Thought Leadership Issue 2 Ensuring Quality & Regulatory Compliance when Collaborating with a Service Provider I N T R O D U C T I O N In recent years, the pharmaceutical industry has given greater
More informationType of Activity. Universal Activity Number L04-P
Below are the pharmacy designated Universal Activity Numbers (UANs) and type of activity that is applicable for each of the following program offerings Session # Title 104 Impact of Biologics, Vaccines,
More informationDigital Strategy & Innovation for Medical Affairs
Digital Strategy & Innovation for Medical Affairs February 11-13, 2019 Philadelphia, PA With the Medical function drastically changing in many organizations, this is undoubtedly an exciting time to work
More informationThe Role of the CRO in Effective Risk-Based Monitoring
New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging
More information7 th Annual Clinical Data Integration & Management March 20 th 21 st Princeton, NJ
7 th Annual Clinical Data Integration & Management March 20 th 21 st Princeton, NJ 2018 Speaking faculty Audrey Hill, Senior Director, Data Management, Advaxis Abhijit Parab, Director, Clinical Data Management
More informationAbout Arena s Clinical Trials Series Speakers Includes:
About Arena s Clinical Trials Series The Clinical Trials Conference series launched over a decade ago and now runs in more than 14 locations worldwide. The acclaimed series is a platform for biopharmaceutical
More informationWhite Paper INTRODUCING A COMPLEXITY SCORING SYSTEM IN CONTRACT NEGOTIATION
White Paper INTRODUCING A COMPLEXITY SCORING SYSTEM IN CONTRACT NEGOTIATION Table of Contents 1. Introduction... 3 2. The Key Drivers For Study Startup Performance... 3 3. Contracts Negotiation Parallel
More informationRegulatory Information Management
Regulatory Information Management Hotel Meliá Avenida América, Madrid http://www.reginfomanagement.com/ Day 1 - Tuesday 26 April 2016 08:30-09:00 Conference Registration 09:00-09:10 Opening remarks from
More informationMeeting temperature requirements in a changing environment
Meeting temperature requirements in a changing environment After an extremely successful launch in 2017 and great growth for the 2018 edition, Temperature Controlled Logistics in Biopharmaceuticals will
More information